You are here

Optimi Health Corp.

Optimi Health Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
OPTI
CSE Index: 
Currency: 

Optimi Health is an end-to-end Canadian-based drug manufacturer and formulator licensed by Health Canada to produce and supply natural, GMP-grade psilocybin and synthetic psychedelic substances, as well as functional mushrooms that focus on the health and wellness markets. Built with the purpose of manufacturing pre-clinical to commercial scale Active Pharmaceutical Ingredients and finished product, the Issuer’s two GMP facilities in Princeton, British Columbia have fully integrated quality management systems in place, which include regular facility audits and external qualifications of all raw material and component suppliers to ensure the highest level of compliance. The Issuer’s goal is to be the number one trusted, compassionate supplier of safe drug products throughout the world. 

You are here

Optimi Health Corp. (OPTI)

SEDAR Information

Company Info

Address
330 – 1122 Mainland Street
Vancouver, BC V6B 5L1
Canada
Phone
778-761-4551
Email
investors@optimihealth.ca
Website
http://www.optimihealth.ca
Listing date
Tuesday, February 23, 2021
Transfer Agent
Endeavor Trust Corporation
Investor Relations
Kidder Management Group Inc.
Email
investors@optimihealth.ca
Auditor
Smythe LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
86,899,316
Reserved for Issuance: 
8,177,029

Company Officers

Bill Ciprick, Chief Executive Officer
Bryan Safarik, Chief Operating Officer
Dane Stevens, Chief Marketing Officer
Jacob Safarik, Chief Financial Officer
Leah Hodges, Corporate Secretary

Bulletins

22/02/2023

2023-0217 - Expiry - Optimi Health Corp. 24FEB2023 Warrants (OPTI.WT)

le 22 février/February 2023

Optimi Health Corp. 24FEB2023 Warrants listed on February 25, 2021 will expire on February 24, 2023.

Settlement Terms:  All trades February 22 and 23 will settle for cash next day. Trades on February 24, 2023 will be for cash same day.

The warrants will be halted at noon and delisted at market close February 24, 2023.

________________________

Advertisement

Publicité

Latest CSE News

Upcoming Events

Benzinga Cannabis Capital Conference

Benzinga Cannabis Capital Conference

Tuesday, April 11, 2023 - 8:00am to Wednesday, April 12, 2023 - 5:00pm